Literature DB >> 26301644

In-hospital management of acute heart failure: Practical recommendations and future perspectives.

Dimitrios Farmakis1, John Parissis2, Apostolos Karavidas3, Charalambos Karvounis4, Filippos Triposkiadis5, Gerasimos Filippatos2, John Lekakis2.   

Abstract

Acute heart failure (AHF) represents the first reason for hospitalization in the elderly and despite therapeutic advances, remains a syndrome with significant morbidity and dismal prognosis. Hospitalization for AHF, on the other hand, is the single most important contributor to the huge financial burden related to HF. As a result, there is a significant unmet need for more effective in-hospital management of patients with AHF in order to improve outcomes, reduce readmission rate and alleviate the socioeconomic burden of the syndrome. The in-hospital management of AHF patients may schematically be divided into three phases, an early phase of intensive management of congestion and/or hypoperfusion, an intermediate phase of transition to oral life-saving medications and a late phase of discharge and transition to outpatient management. In the present paper, we attempt to provide a concise and practical roadmap for each of the above phases, focusing mainly on defining clinical and laboratory criteria for the evaluation of patients and on describing therapeutic algorithms that summarize the available evidence and guidelines. In addition, we highlight some key open issues that need to be addressed by future research.
Copyright © 2015. Published by Elsevier Ireland Ltd.

Entities:  

Keywords:  Acute heart failure; Congestion; Diuretics; Hospitalization; Inotropes; Life-saving therapies

Mesh:

Year:  2015        PMID: 26301644     DOI: 10.1016/j.ijcard.2015.08.030

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  9 in total

1.  Acute Heart Failure in the Emergency Department: Respiratory Rate as a Risk Predictor.

Authors:  Eftychios Siniorakis; Spyridon Arvanitakis; Christina Tsitsimpikou; Konstantinos Tsarouhas; Panagiotis Tzevelekos; Stamatia Panta; Fotini Aivalioti; Constantinos Zampelis; Filippos Triposkiadis; Sotiria Limberi
Journal:  In Vivo       Date:  2018 Jul-Aug       Impact factor: 2.155

2.  Differential effects of inotropes and inodilators on renal function in acute cardiac care.

Authors:  Endre Zima; Dimitrios Farmakis; Piero Pollesello; John T Parissis
Journal:  Eur Heart J Suppl       Date:  2020-05-15       Impact factor: 1.803

Review 3.  How to develop a national heart failure clinics network: a consensus document of the Hellenic Heart Failure Association.

Authors: 
Journal:  ESC Heart Fail       Date:  2020-02-26

Review 4.  Angiotensin receptor-neprilysin inhibition in patients with acute decompensated heart failure: an expert consensus position paper.

Authors:  Argyrios Ntalianis; Christina Chrysohoou; George Giannakoulas; Grigorios Giamouzis; Apostolos Karavidas; Aikaterini Naka; Constantinos H Papadopoulos; Sotirios Patsilinakos; John Parissis; Dimitrios Tziakas; John Kanakakis
Journal:  Heart Fail Rev       Date:  2021-05-01       Impact factor: 4.654

Review 5.  Effects and Safety of Sacubitril/Valsartan for Patients with Myocardial Infarction: A Systematic Review and Meta-Analysis.

Authors:  Lang Liu; Xiaofang Ding; Yaxiang Han; Jianfeng Lv
Journal:  J Healthc Eng       Date:  2022-01-05       Impact factor: 2.682

6.  Temporal Change in Renoprotective Effect of Tolvaptan on Patients with Heart Failure: AURORA Study.

Authors:  Masami Nishino; Yasuyuki Egami; Akihiro Tanaka; Shodai Kawanami; Hiroki Sugae; Kohei Ukita; Akito Kawamura; Hitoshi Nakamura; Yutaka Matsuhiro; Koji Yasumoto; Masaki Tsuda; Naotaka Okamoto; Yasuharu Matsunaga-Lee; Masamichi Yano; Jun Tanouchi
Journal:  J Clin Med       Date:  2022-02-13       Impact factor: 4.241

7.  Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure.

Authors:  Zeyu Wang; Xin Pan; Hong Xu; You Wu; Xiaomin Jia; Yiling Fang; Yi Lu; Yawei Xu; Ji Zhang; Yang Su
Journal:  Front Cardiovasc Med       Date:  2022-02-09

Review 8.  Anticoagulation for atrial fibrillation in active cancer.

Authors:  Dimitrios Farmakis; Pavlos Papakotoulas; Eleni Angelopoulou; Theodoros Bischiniotis; George Giannakoulas; Panagiotis Kliridis; Dimitrios Richter; Ioannis Paraskevaidis
Journal:  Oncol Lett       Date:  2022-02-17       Impact factor: 2.967

9.  B-Type Natriuretic Peptide at Admission Is a Predictor of All-Cause Mortality at One Year after the First Acute Episode of New-Onset Heart Failure with Preserved Ejection Fraction.

Authors:  Liviu-Nicolae Ghilencea; Gabriel-Cristian Bejan; Marilena-Brîndusa Zamfirescu; Ana Maria Alexandra Stănescu; Lavinia-Lucia Matei; Laura-Maria Manea; Ismail Dogu Kilic; Serban-Mihai Bălănescu; Andreea-Catarina Popescu; Saul Gareth Myerson
Journal:  J Pers Med       Date:  2022-05-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.